Table of Contents

1 Study Coverage

• 1.1 Neurosimulation Product
• 1.2 Market Segments
• 1.3 Key Manufacturers Covered
• 1.4 Market by Type
  • 1.4.1 Global Neurosimulation Market Size Growth Rate by Product
  • 1.4.2 Sacral Nerve Stimulators
  • 1.4.3 Spinal Cord Stimulators
  • 1.4.4 Gastric Electric Stimulators
  • 1.4.5 Deep Brain Stimulators
  • 1.4.6 Vagus Nerve Stimulators
• 1.5 Market by End User
  • 1.5.1 Global Neurosimulation Market Size Growth Rate by End User
  • 1.5.2 Epilepsy
  • 1.5.3 Depression
  • 1.5.4 Dystonia
  • 1.5.5 Pain Management
  • 1.5.6 Parkinson’s Disease
  • 1.5.7 Others
• 1.6 Study Objectives
• 1.7 Years Considered

2 Executive Summary

• 2.1 Global Neurosimulation Market Size
  • 2.1.1 Global Neurosimulation Revenue 2014-2025
  • 2.1.2 Global Neurosimulation Sales 2014-2025
• 2.2 Neurosimulation Growth Rate by Regions
  • 2.2.1 Global Neurosimulation Sales by Regions
  • 2.2.2 Global Neurosimulation Revenue by Regions

3 Breakdown Data by Manufacturers

• 3.1 Neurosimulation Sales by Manufacturers
  • 3.1.1 Neurosimulation Sales by Manufacturers
  • 3.1.2 Neurosimulation Sales Market Share by Manufacturers
  • 3.1.3 Global Neurosimulation Market Concentration Ratio (CR5 and HHI)
• 3.2 Neurosimulation Revenue by Manufacturers
  • 3.2.1 Neurosimulation Revenue by Manufacturers (2014-2019)
  • 3.2.2 Neurosimulation Revenue Share by Manufacturers (2014-2019)
• 3.3 Neurosimulation Price by Manufacturers
• 3.4 Neurosimulation Manufacturing Base Distribution, Product Types
  • 3.4.1 Neurosimulation Manufacturers Manufacturing Base Distribution, Headquarters
  • 3.4.2 Manufacturers Neurosimulation Product Type
  • 3.4.3 Date of International Manufacturers Enter into Neurosimulation Market
• 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Product

• 4.1 Global Neurosimulation Sales by Product
• 4.2 Global Neurosimulation Revenue by Product
• 4.3 Neurosimulation Price by Product

5 Breakdown Data by End User

• 5.1 Overview
• 5.2 Global Neurosimulation Breakdown Data by End User

6 North America

• 6.1 North America Neurosimulation by Countries
  • 6.1.1 North America Neurosimulation Sales by Countries
  • 6.1.2 North America Neurosimulation Revenue by Countries
  • 6.1.3 United States
  • 6.1.4 Canada
  • 6.1.5 Mexico
• 6.2 North America Neurosimulation by Product
• 6.3 North America Neurosimulation by End User

7 Europe

• 7.1 Europe Neurosimulation by Countries
  • 7.1.1 Europe Neurosimulation Sales by Countries
  • 7.1.2 Europe Neurosimulation Revenue by Countries
  • 7.1.3 Germany
  • 7.1.4 France
  • 7.1.5 UK
  • 7.1.6 Italy
  • 7.1.7 Russia
• 7.2 Europe Neurosimulation by Product
• 7.3 Europe Neurosimulation by End User

8 Asia Pacific

• 8.1 Asia Pacific Neurosimulation by Countries
  • 8.1.1 Asia Pacific Neurosimulation Sales by Countries
  • 8.1.2 Asia Pacific Neurosimulation Revenue by Countries
  • 8.1.3 China
  • 8.1.4 Japan
  • 8.1.5 Korea
  • 8.1.6 India
  • 8.1.7 Australia
  • 8.1.8 Indonesia
  • 8.1.9 Malaysia
  • 8.1.10 Philippines
  • 8.1.11 Thailand
  • 8.1.12 Vietnam
  • 8.1.13 Singapore
• 8.2 Asia Pacific Neurosimulation by Product
• 8.3 Asia Pacific Neurosimulation by End User

9 Central & South America

• 9.1 Central & South America Neurosimulation by Countries
  • 9.1.1 Central & South America Neurosimulation Sales by Countries
  • 9.1.2 Central & South America Neurosimulation Revenue by Countries
  • 9.1.3 Brazil
• 9.2 Central & South America Neurosimulation by Product
• 9.3 Central & South America Neurosimulation by End User

10 Middle East and Africa

• 10.1 Middle East and Africa Neurosimulation by Countries
  • 10.1.1 Middle East and Africa Neurosimulation Sales by Countries
  • 10.1.2 Middle East and Africa Neurosimulation Revenue by Countries
  • 10.1.3 GCC Countries
  • 10.1.4 Turkey
  • 10.1.5 Egypt
  • 10.1.6 South Africa
• 10.2 Middle East and Africa Neurosimulation by Product
• 10.3 Middle East and Africa Neurosimulation by End User

11 Company Profiles

• 11.1 Medtronic
  • 11.1.1 Medtronic Company Details
  • 11.1.2 Company Business Overview
  • 11.1.3 Medtronic Neurosimulation Sales, Revenue and Gross Margin (2014-2019)
  • 11.1.4 Medtronic Neurosimulation Products Offered
  • 11.1.5 Medtronic Recent Development
• 11.2 Boston Scientific
  • 11.2.1 Boston Scientific Company Details
  • 11.2.2 Company Business Overview
  • 11.2.3 Boston Scientific Neurosimulation Sales, Revenue and Gross Margin (2014-2019)
  • 11.2.4 Boston Scientific Neurosimulation Products Offered
  • 11.2.5 Boston Scientific Recent Development
• 11.3 Abbott
  • 11.3.1 Abbott Company Details
  • 11.3.2 Company Business Overview
  • 11.3.3 Abbott Neurosimulation Sales, Revenue and Gross Margin (2014-2019)
  • 11.3.4 Abbott Neurosimulation Products Offered
  • 11.3.5 Abbott Recent Development
• 11.4 Cyberonics
  • 11.4.1 Cyberonics Company Details
  • 11.4.2 Company Business Overview
  • 11.4.3 Cyberonics Neurosimulation Sales, Revenue and Gross Margin (2014-2019)
  • 11.4.4 Cyberonics Neurosimulation Products Offered
  • 11.4.5 Cyberonics Recent Development

12 Future Forecast

• 12.1 Neurosimulation Market Forecast by Regions
  • 12.1.1 Global Neurosimulation Sales Forecast by Regions 2019-2025
  • 12.1.2 Global Neurosimulation Revenue Forecast by Regions 2019-2025
• 12.2 Neurosimulation Market Forecast by Product
  • 12.2.1 Global Neurosimulation Sales Forecast by Product 2019-2025
  • 12.2.2 Global Neurosimulation Revenue Forecast by Product 2019-2025
• 12.3 Neurosimulation Market Forecast by End User
• 12.4 North America Neurosimulation Forecast
• 12.5 Europe Neurosimulation Forecast
• 12.6 Asia Pacific Neurosimulation Forecast
• 12.7 Central & South America Neurosimulation Forecast
• 12.8 Middle East and Africa Neurosimulation Forecast

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis

• 13.1 Market Opportunities and Drivers
• 13.2 Market Challenges
• 13.3 Market Risks/Restraints
• 13.4 Macroscopic Indicators

14 Value Chain and Sales Channels Analysis

• 14.1 Value Chain Analysis
• 14.2 Neurosimulation Customers
• 14.3 Sales Channels Analysis
  • 14.3.1 Sales Channels
  • 14.3.2 Distributors

15 Research Findings and Conclusion

16 Appendix

• 16.1 Research Methodology
  • 16.1.1 Methodology/Research Approach
  • 16.1.2 Data Source
• 16.2 Author Details

Neuromodulation is a process that makes use of an implantable medical device to modulate and alter neural activities for therapeutic purposes. Devices that are used for neuromodulation are called as neurostimulators or neurostimulation devices and usually function by bringing about stimulation of nerve impulses or by inhibition of pain signals produced at target sites that include autonomic nervous system, deep nuclei of the brain, peripheral nervous system, and central nervous system.
The global Neurosimulation market is valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Neurosimulation market based on company, product type, end user and key regions.

This report studies the global market size of Neurosimulation in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Neurosimulation in these regions.
This research report categorizes the global Neurosimulation market by top players/brands, region, type and end user. This report also studies the global Neurosimulation market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.

The following manufacturers are covered in this report, with sales, revenue, market share for each company:
Medtronic
Boston Scientific
Abbott
Cyberonics

Market size by Product
Sacral Nerve Stimulators
Spinal Cord Stimulators
Gastric Electric Stimulators
Deep Brain Stimulators
Vagus Nerve Stimulators
Market size by End User
Epilepsy
Depression
Dystonia
Pain Management
Parkinson’s Disease
Others

Market size by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa

The study objectives of this report are:
To study and analyze the global Neurosimulation market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
To understand the structure of Neurosimulation market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Neurosimulation companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of Neurosimulation submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

In this study, the years considered to estimate the market size of Neurosimulation are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025

This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Neurosimulation market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.